| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adverse drug reactions to therapy with European Mistletoe Viscum album L.
|
Steele, Megan
|
|
2015
|
22 |
S1 |
p. S17-S18
2 p.
|
artikel
|
| 2 |
Author Index
|
|
|
2015
|
22 |
S1 |
p. S31-S32
2 p.
|
artikel
|
| 3 |
Cancer-related fatigue: symptoms, diagnosis and therapy
|
Zänker, Kurt S.
|
|
2015
|
22 |
S1 |
p. S13-S14
2 p.
|
artikel
|
| 4 |
Clinical experiences in the topical treatment of skin lesions with Viscum album, Extractum resinosum 10%, Unguentum – a retrospective case series study
|
Mösch, Pedro
|
|
2015
|
22 |
S1 |
p. S28-
1 p.
|
artikel
|
| 5 |
Comparative investigation of nucleosides in mistletoes (Viscum album L.) from different host trees
|
Wurster, Martina
|
|
2015
|
22 |
S1 |
p. S23-S24
2 p.
|
artikel
|
| 6 |
Critical review of the methods applied in a study with mistletoe in pancreatic cancer patients
|
Tröger, Wilfried
|
|
2015
|
22 |
S1 |
p. S6-S7
2 p.
|
artikel
|
| 7 |
Current state of clinical research on mistletoe therapy in oncology
|
Kiene, Helmut
|
|
2015
|
22 |
S1 |
p. S4-S5
2 p.
|
artikel
|
| 8 |
Dandelion (Taraxacum officinale) extracts supply antitumour effects of mistletoe in pediatric cancer cells
|
Menke, Katrin
|
|
2015
|
22 |
S1 |
p. S25-S26
2 p.
|
artikel
|
| 9 |
Development of the regulatory assessment of anthroposophic parenteral mistletoe preparations
|
Kirch, Marion
|
|
2015
|
22 |
S1 |
p. S4-
1 p.
|
artikel
|
| 10 |
Editorial Board
|
|
|
2015
|
22 |
S1 |
p. IFC-
1 p.
|
artikel
|
| 11 |
Evaluation of an anthroposophic supportive treatment intervention (ASTI) in children with malignant diseases during intensive chemotherapy
|
Seifert, Georg
|
|
2015
|
22 |
S1 |
p. S18-
1 p.
|
artikel
|
| 12 |
Foreword
|
Scheer, Rainer
|
|
2015
|
22 |
S1 |
p. S1-
1 p.
|
artikel
|
| 13 |
High-dose mistletoe therapy in children – first experiences in children with advanced cancer diseases
|
Zuzak, Tycho J
|
|
2015
|
22 |
S1 |
p. S21-S22
2 p.
|
artikel
|
| 14 |
Immunology of mistletoe extracts
|
Klein, Reinhild
|
|
2015
|
22 |
S1 |
p. S4-
1 p.
|
artikel
|
| 15 |
Insight into mistletoe´s mechanism of action of targeting pediatric Ewing Sarcoma
|
Twardziok, Monika
|
|
2015
|
22 |
S1 |
p. S25-
1 p.
|
artikel
|
| 16 |
Interaction of mistletoe preparations (Viscum album) with antitumour effects of several standard anticancer drugs in vitro
|
Weissenstein, Ulrike
|
|
2015
|
22 |
S1 |
p. S12-
1 p.
|
artikel
|
| 17 |
Intravesical mistletoe extract instillation for urothelial carcinoma of the bladder
|
Sterner, Martin-Günther
|
|
2015
|
22 |
S1 |
p. S21-
1 p.
|
artikel
|
| 18 |
Intravesical mistletoe plant extract in patients with non muscle invasive bladder Cancer - a phase III efficacy study – current status
|
Eisenbraun, Jürgen
|
|
2015
|
22 |
S1 |
p. S29-
1 p.
|
artikel
|
| 19 |
Investigation of the impact of Viscum album preparations on the proliferation of the equine sarcoid cell line E42/02
|
Felenda, Jennifer
|
|
2015
|
22 |
S1 |
p. S25-
1 p.
|
artikel
|
| 20 |
Is mistletoe therapy indicated to reduce cancer-related fatigue and insomnia in cancer patients? – a review
|
Kröz, Matthias
|
|
2015
|
22 |
S1 |
p. S29-
1 p.
|
artikel
|
| 21 |
Liposomal formulations of mistletoe produced by centrifugal technologies suitable for cancer therapy
|
Leneweit, Gero
|
|
2015
|
22 |
S1 |
p. S9-S10
2 p.
|
artikel
|
| 22 |
Medicinal use of mistletoes in Mato Grosso, Brazil
|
Rieder, Arno
|
|
2015
|
22 |
S1 |
p. S11-
1 p.
|
artikel
|
| 23 |
Methodological requirements for a pharmacoeconomic study of oncological mistletoe therapy
|
Reif, Marcus
|
|
2015
|
22 |
S1 |
p. S10-
1 p.
|
artikel
|
| 24 |
Mistletoe as complementary treatment in patients with advanced non-small-cell lung cancer: Should it be an integral part of treatment, based on a published randomized phase II study?
|
Bar-Sela, Gil
|
|
2015
|
22 |
S1 |
p. S15-
1 p.
|
artikel
|
| 25 |
Mistletoe extracts stimulate immature dendritic cells and prevent tumour-induced immunosuppression in vitro
|
Sanchez, Ann Sophie
|
|
2015
|
22 |
S1 |
p. S28-S29
2 p.
|
artikel
|
| 26 |
Mistletoe extract therapy versus no antineoplastic therapy: a randomized clinical trial on overall survival and quality of life in pancreatic cancer patients
|
Galun, Danijel
|
|
2015
|
22 |
S1 |
p. S6-
1 p.
|
artikel
|
| 27 |
Mistletoe in the German medical AWMF S2- and S3-guidelines
|
Langhorst, Jost
|
|
2015
|
22 |
S1 |
p. S7-
1 p.
|
artikel
|
| 28 |
Mistletoe lectin in concert
|
Maletzki, Claudia
|
|
2015
|
22 |
S1 |
p. S12-
1 p.
|
artikel
|
| 29 |
Mistletoe lectin- (ML-1) and viscotoxin (VT) antibodies during therapy with Viscum album in patients with breast cancer
|
Hagens, Cornelia v.
|
|
2015
|
22 |
S1 |
p. S27-
1 p.
|
artikel
|
| 30 |
Mistletoe plant extract in patients with non muscle-invasive bladder cancer - results from a phase Ib/IIa single group dose escalation study
|
Eisenbraun, Jürgen
|
|
2015
|
22 |
S1 |
p. S15-S16
2 p.
|
artikel
|
| 31 |
Mistletoes found in the urban environment of Cáceres (Mato Grosso, Brazil)
|
da Silva, Orivaldo Benedito
|
|
2015
|
22 |
S1 |
p. S23-
1 p.
|
artikel
|
| 32 |
Mistletoe therapy in a general practice and its impact on the physician
|
Meyer, Frank
|
|
2015
|
22 |
S1 |
p. S20-
1 p.
|
artikel
|
| 33 |
Palliative mistletoe therapy in pancreatic cancer patients undergoing first-line chemotherapy (PALM-PAN)
|
Reif, Marcus
|
|
2015
|
22 |
S1 |
p. S29-S30
2 p.
|
artikel
|
| 34 |
Phenolic profiles of Viscum album L. subspecies from different host trees
|
Gärtner, Tania
|
|
2015
|
22 |
S1 |
p. S24-
1 p.
|
artikel
|
| 35 |
Plant lectins: potential antineoplastic and antiviral drugs
|
Kreis, Wolfgang
|
|
2015
|
22 |
S1 |
p. S3-
1 p.
|
artikel
|
| 36 |
Postrelapse disease-free survival with adjuvant mistletoe versus oral Etoposide in osteosarcoma patients: a randomized study
|
Longhi, Alessandra
|
|
2015
|
22 |
S1 |
p. S17-
1 p.
|
artikel
|
| 37 |
Pre-clinical and clinical investigations on Viscum album preparations
|
Herrick, Anja
|
|
2015
|
22 |
S1 |
p. S24-S25
2 p.
|
artikel
|
| 38 |
Purpose and methods of evaluation of the Mistletoe Vademecum
|
Debus, Marion
|
|
2015
|
22 |
S1 |
p. S20-S21
2 p.
|
artikel
|
| 39 |
Quality of Life (QoL) in children and adolescents with paediatric malignancies under anthroposophic supportive treatment
|
Calaminus, Gabriele
|
|
2015
|
22 |
S1 |
p. S18-S19
2 p.
|
artikel
|
| 40 |
Review: Mistletoe therapy in gastrointestinal tumours
|
Matthes, Harald
|
|
2015
|
22 |
S1 |
p. S8-
1 p.
|
artikel
|
| 41 |
Safety of intravenous application of a mistletoe extract – results from a phase I dose escalation study in patients with advanced cancer
|
Huber, Roman
|
|
2015
|
22 |
S1 |
p. S16-
1 p.
|
artikel
|
| 42 |
Study of the time-dependent uptake of mistletoe lectin by cultured tumour cells
|
Mulsow, Katharina
|
|
2015
|
22 |
S1 |
p. S9-
1 p.
|
artikel
|
| 43 |
The lectin and viscotoxin pattern of European mistletoe: isolation and quantification of the mistletoe lectins, their subunits and the viscotoxins
|
Pfüller, Uwe
|
|
2015
|
22 |
S1 |
p. S3-S4
2 p.
|
artikel
|
| 44 |
The role of intralesional mistletoe application in the treatment of breast cancer. Three case-reports
|
Maris, Bartholomeus
|
|
2015
|
22 |
S1 |
p. S21-
1 p.
|
artikel
|
| 45 |
Tumour cell derived effects on monocyte/macrophage polarization and function and modulatory potential of Viscum album lipophilic extract in vitro
|
Estko, Myriam
|
|
2015
|
22 |
S1 |
p. S27-S28
2 p.
|
artikel
|
| 46 |
Viscum album and its anti-inflammatory effect: angle of cytokine induced selective inhibition of COX-2
|
Saha, Chaitrali
|
|
2015
|
22 |
S1 |
p. S12-S13
2 p.
|
artikel
|
| 47 |
Vorwort
|
Scheer, Rainer
|
|
2015
|
22 |
S1 |
p. S2-
1 p.
|
artikel
|
| 48 |
White blood cell and lymphocyte count in tumour patients and its evolution by Viscum treatment, a retrospective explorative trial
|
Kuehn, Jürgen J.
|
|
2015
|
22 |
S1 |
p. S19-
1 p.
|
artikel
|
| 49 |
Whole mistletoe extract viscumTT has anti-cancer effects in osteosarcoma in vitro and in vivo
|
Kleinsimon, Susann
|
|
2015
|
22 |
S1 |
p. S11-S12
2 p.
|
artikel
|
Tijdschrift beschrijving